Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Clinical trial NCT01691521 · COMPLETED
Trial details
- NCT number
- NCT01691521
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-08
- Primary completion
- 2014-01-01
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.